Fluorescence spectroscopy


 

Dr. Waggoner’s research has focused on development of fluorescence-based detection systems for biology and biotechnology. He spent 20 years at Amherst College then Carnegie Mellon University before establishing a startup company with Lans Taylor called Biological Detection Systems. After acquisition of BDS by Amersham Biosciences, Dr Waggoner joined Amersham for four years to develop high-throughput fluorescence detection systems for pharmaceutical drug screening. In 2000 Dr Waggoner returned to Carnegie Mellon University as Director of the Molecular Biosensor and Imaging Center. The cyanine dye fluorescent labeling reagents developed in the laboratory have become widely used in industry and academic research for multicolor analysis of proteins, nucleic acids, cells and tissues with imaging microscopes and flow cytometers. Dr. Waggoner is currently leading the research focusing on the development of molecular biosensors for studying living cells within tissues. The Center was recently funded by NIH as a National Technology Center for Networks and Pathways. The goal for the TCNP is to develop a new class of biosensors for time-lapse imaging of important biological regulatory molecules in the 3-dimensional space of living biological cells.

 


Education

PhD, University of Oregon

Postdoctoral Training

Yale University


 

Carnegie Mellon University
Department of Biological Sciences
294B Mellon Institute
4400 Fifth Avenue
Pittsburgh, PA 15213 

Phone: (412) 268-3456

E-mail: waggoner@andrew.cmu.edu 

Visit website